TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea · Delayed Price · Currency is KRW 989.00
-42.00 (-4.07%)
Jan 30, 2026, 3:30 PM KST
TELCON RF PHARMACEUTICAL. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -33,505 | -26,320 | 13,906 | -42,084 | -23,098 | -40,893 |
Depreciation & Amortization | 4,631 | 4,507 | 4,244 | 4,281 | 4,200 | 4,397 |
Loss (Gain) From Sale of Assets | -486.92 | -17.27 | 14.8 | -34.38 | 250.45 | 195.64 |
Asset Writedown & Restructuring Costs | 860.74 | 1,097 | 64.8 | 4,411 | 3,005 | 4,231 |
Loss (Gain) From Sale of Investments | 4,820 | -1,275 | -13,466 | 13,146 | -4,626 | -9,010 |
Loss (Gain) on Equity Investments | 17,232 | 24,684 | -469.53 | 17,868 | 13,196 | 39,204 |
Provision & Write-off of Bad Debts | 24.24 | 206.34 | 251.8 | 746.56 | -19.19 | -2,915 |
Other Operating Activities | 9,825 | 618.75 | 963.05 | 2,648 | 7,383 | 3,557 |
Change in Accounts Receivable | -5,267 | -3,908 | -6,563 | -1,450 | -791.38 | 6,131 |
Change in Inventory | -507 | 528.74 | -717.74 | -1,684 | -677.17 | -199.08 |
Change in Accounts Payable | 1,935 | 1,572 | 503.37 | 646.52 | 60.21 | 136.69 |
Change in Other Net Operating Assets | 283.36 | -474.55 | 133.25 | -586.66 | 758.06 | -2,033 |
Operating Cash Flow | -155.38 | 1,219 | -1,135 | -2,093 | -358.56 | 2,803 |
Operating Cash Flow Growth | - | - | - | - | - | -44.09% |
Capital Expenditures | -1,032 | -4,968 | -3,820 | -819.43 | -2,254 | -1,132 |
Sale of Property, Plant & Equipment | - | 18.05 | 5.88 | 66.81 | 60.24 | 196.69 |
Cash Acquisitions | -30.98 | - | - | - | - | - |
Divestitures | 505.56 | - | - | - | - | - |
Sale (Purchase) of Intangibles | -5.81 | -7.13 | -18 | -14.52 | -3,559 | -3,485 |
Investment in Securities | -4,247 | -44,536 | 419.38 | -7,082 | 6,508 | -57,921 |
Other Investing Activities | 9.1 | 38.83 | -32.32 | 46.34 | 124.26 | 237.14 |
Investing Cash Flow | -6,381 | -44,084 | -10,525 | -7,885 | 879.02 | -62,078 |
Short-Term Debt Issued | - | 36,600 | - | 200 | - | - |
Long-Term Debt Issued | - | 29,780 | 13,108 | 1,000 | - | 81,211 |
Total Debt Issued | 36,280 | 66,380 | 13,108 | 1,200 | - | 81,211 |
Short-Term Debt Repaid | - | -18,000 | -200 | - | - | - |
Long-Term Debt Repaid | - | -10,737 | -2,947 | -4,640 | -1,922 | -12,968 |
Total Debt Repaid | -42,117 | -28,737 | -3,147 | -4,640 | -1,922 | -12,968 |
Net Debt Issued (Repaid) | -5,837 | 37,643 | 9,961 | -3,440 | -1,922 | 68,243 |
Issuance of Common Stock | 40,298 | - | - | - | - | 66.22 |
Other Financing Activities | 7.63 | 8.55 | 484.74 | - | 31.01 | 17.73 |
Financing Cash Flow | 34,468 | 37,651 | 10,445 | -3,440 | -1,891 | 68,327 |
Foreign Exchange Rate Adjustments | 3.46 | 0.6 | -0.46 | -43.32 | 24.42 | -10.58 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | -226.56 |
Net Cash Flow | 27,936 | -5,213 | -1,214 | -13,462 | -1,346 | 8,814 |
Free Cash Flow | -1,187 | -3,749 | -4,954 | -2,912 | -2,613 | 1,671 |
Free Cash Flow Growth | - | - | - | - | - | -58.80% |
Free Cash Flow Margin | -2.72% | -9.90% | -13.64% | -10.46% | -6.90% | 5.04% |
Free Cash Flow Per Share | -28.55 | -105.63 | -110.43 | -70.69 | -99.13 | 65.08 |
Cash Interest Paid | 2,682 | 1,304 | 553.73 | 861.4 | 2,419 | 613.83 |
Cash Income Tax Paid | - | 200.01 | 45.14 | -27.4 | 40.1 | 21.13 |
Levered Free Cash Flow | 5,957 | 10,349 | -5,322 | 316 | -7,715 | -1,038 |
Unlevered Free Cash Flow | 9,403 | 12,699 | -4,945 | 980.21 | -2,901 | 742.05 |
Change in Working Capital | -3,555 | -2,282 | -6,644 | -3,074 | -650.28 | 4,036 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.